CAS 6952-59-6 - China Factory, Suppliers, Manufacturers

CAS 6952-59-6, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

3-Bromobenzonitrile CAS 6952-59-6 Purity 99.0 (GC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 3-Bromobenzonitrile CAS 6952-59-6 Purity >99.0% (GC) Factory
Read More

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...

2022.09.30 04:18:22
2022.08.06 02:58:52
2022.05.25 16:59:13
2022.03.25 15:45:35
2022.02.17 07:56:13
2021.12.27 01:39:44

CAS 6952-59-6 - China Factory, Suppliers, Manufacturers

Related Products

3-Bromobenzonitrile CAS 6952-59-6 Purity >99.0% (GC) Factory

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Purity ≥99.0% (HPLC) Trelagliptin Succinate Intermediate Factory

4-Aminophenylboronic Acid Pinacol Ester CAS 214360-73-3 Purity >99.0% (GC) Factory High Quality

6-Iodo-4-Hydroxyquinazoline CAS 16064-08-7 Purity >98.5% (HPLC) Factory

H-Lys(Z)-OMe·HCl CAS 27894-50-4 Purity >98.0% (HPLC)

Boc-Dap(Fmoc)-OH CAS 122235-70-5 Purity >98.0% (HPLC)

Neopentyl Glycol (NPG) CAS 126-30-7 Purity ≥99.5% (GC)

Phthalylsulfathiazole CAS 85-73-4 Purity >95.0% (T) Factory High Quality

Adenine Hydrochloride Hydrate CAS 6055-72-7 Assay ≥99.0% Factory

3,4-Dihydro-2H-Isoquinolin-1-One CAS 1196-38-9 Purity >97.0% (HPLC)

5-Hydroxyquinoline (5-Quinolinol) CAS 578-67-6 Purity >99.0% (HPLC)

L-Cyclohexylalanine CAS 27527-05-5 Purity >99.0% (HPLC)

Boc-Dap(Z)-OH CAS 65710-57-8 Purity >98.0% (HPLC)

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The “Summit on COVID-19 Diagnostics & Treatment”

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Xi presents award to top scientists

2022.09.30 04:18:22

2022.08.06 02:58:52

2022.05.25 16:59:13

2022.03.25 15:45:35

2022.02.17 07:56:13

2021.12.27 01:39:44

related search